DXL swings to $35.9M loss, announces FullBeauty merger as sales decline accelerates

Filed March 19, 2026 · Period ending January 31, 2026 · Compared to 10-K Mar 20, 2025 · ~2 min read

Key Changes

• high

  Net loss of $35.9M vs. $3.1M income prior year, driven by 6.9% sales decline, $20.4M tax valuation allowance, and $4.2M merger costs. Adjusted EBITDA collapsed 92% to $1.6M despite only 7% revenue drop.

  MD&A: Financial Results verify on EDGAR →
• high

  Announced merger with FullBeauty ($0.7B direct-to-consumer plus-size retailer). Post-merger, FullBeauty shareholders own 55%, DXL shareholders 45%. Expected close Q2 fiscal 2026, subject to shareholder approval.

  MD&A: FullBeauty Merger verify on EDGAR →
• high

  Recorded $20.4M non-cash charge for full valuation allowance on deferred tax assets. Management concluded near-term operating losses outweigh positive evidence for realizability despite long-term profitability expectations.

  MD&A: Valuation Allowance verify on EDGAR →